Israeli Prime Minister Benjamin Netanyahu abruptly canceled a high-stakes delegation to Washington this week after the U.S. didn’t block a United Nation Security Council resolution calling for a ceasefire in Gaza during the Muslim holy month of Ramadan.

In a statement, Netanyahu’s office called the U.S. abstention “a clear retreat from the consistent position of the United States at the Security Council since the beginning of the war.”

The delegation was expected to hold talks on the ongoing war in Gaza as Israeli forces move toward Rafah, where more than a million Palestinians are sheltering from the war that started with Hamas’ deadly Oct. 7 attack on Israelis.

White House national security spokesperson John Kirby said he was “disappointed” that Israel canceled the delegation’s trip.

“It’s a nonbinding resolution,” he told reporters in a White House briefing. “It does not represent a change in our policy at all.”

A fight over abortion pills at the Supreme Court this week could have sweeping consequences for access to mifepristone — even for those who live in blue states. 

It’s the first major abortion case that the High Court has heard since overturning the landmark Roe v. Wade decision last year, allowing states to adopt strict abortion laws.

The court will hear arguments about whether federal regulators overstepped their authority by loosening restrictions to make mifepristone easier to access.

More than half of abortions in the U.S. last year were done through medication.

If the justices uphold a lower court’s ruling, prescribing mifepristone through telemedicine would no longer be allowed. 

There is no legal precedent for a court to override the Food and Drug Administration’s approval of a drug. The case likely would not be decided until the summer. (The Hill)

“Minneapolis just called Uber’s bluff — other cities must follow their lead,” writes Lauren Jacobs of PowerSwitch Action.

“The truth about the ‘veepstakes,’” writes Marc Lotter former aide to Mike Pence and director of strategic communications for the 2020 Trump-Pence campaign.